OBSEVIABack to blog

8 July 2026

What Pharma SMEs Should Ask Before Buying AI Compliance Tools

A buyer’s checklist for regulated teams evaluating AI assistants for documentation, review, and workflow support, without getting lost in vendor demos.

pharma · procurement · AI

Pharmaceutical SMEs are rightly cautious about AI. Validation expectations, data integrity, and patient safety raise the bar. The wrong purchase creates shadow IT; the right one reduces repetitive documentation load under controlled conditions.

Use these questions before you sign anything.

1. Where does our data go?

Ask for a clear data-flow diagram: training use, subprocessors, retention, and whether customer documents can be isolated. “We take security seriously” is not an answer.

2. What is the system of record?

AI tools should not become a second uncontrolled repository of regulated decisions. Confirm how outputs are exported into your QMS, EDMS, or approved workflow, and who approves them.

3. Can we reconstruct decisions?

If an inspector asks why a document said X on a given date, can you show source context, model-assisted draft, human edits, and approver identity?

4. What is explicitly out of scope?

Strong vendors state what the product must not do unsupervised (for example, final batch release, unsupervised regulatory submission text, or automatic SOP effectiveness decisions).

5. How do we measure effectiveness?

Demand a pilot design with baseline metrics: time, rework, deviation in quality of drafts, and user trust. Demo wow is not evidence.

6. How are model updates managed?

Ask how prompt/model changes are communicated and whether you can freeze behavior for a validated process window.

7. What change-control support exists?

Your internal change control still applies. The vendor should make it easier to document intended use, limitations, and periodic review.

Red flags

  • Claims of “autonomous compliance”
  • Unwillingness to support human approval gates
  • Vague subprocessors
  • No pilot instrumentation
  • Pressure to roll out company-wide in month one

A sane buying posture

Start with a narrow intended use, a four-week pilot, and written limitations. Expand only when reviewers trust the drafts and quality metrics hold. In regulated environments, procurement discipline is part of product quality.